DASH for Better Blood Pressure Control

In today’s US, 46% of adults have hypertension (high blood pressure based on current diagnostic criterion)1.  Everyday at our primary care clinic, we give hypertension patients advice on healthy diet and lifestyle.  However, so often I see the puzzled expression in a patient’s face or I get asked directly: but where shall I start?  This […]

Continue reading

Daratumumab for Relapsed or Refractory Multiple Myeloma – a Mini-Review

Abstract Almost all patients with multiple myeloma (MM) who respond to initial therapy will relapse, while some patients do not respond to initial treatment (refractory).  This is a brief review of three seminal studies from 2016 that established foundation for daratumumab-based combination therapy regimens in MM.  These studies have shown that daratumumab, an IgG1 monoclonal […]

Continue reading